HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,127 | -12.6% | 1,094,441 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $1,289 | -20.3% | 1,110,876 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $1,617 | -41.2% | 1,071,124 | -2.5% | 0.00% | -50.0% |
| Q4 2022 | $2,748 | -99.9% | 1,099,050 | +17.1% | 0.00% | -33.3% |
| Q3 2022 | $3,960,000 | +75.8% | 938,352 | +16.2% | 0.01% | +100.0% |
| Q2 2022 | $2,253,000 | -51.2% | 807,384 | -0.0% | 0.00% | -40.0% |
| Q1 2022 | $4,619,000 | -37.0% | 807,503 | +0.6% | 0.01% | -28.6% |
| Q4 2021 | $7,327,000 | +4.6% | 802,568 | +22.5% | 0.01% | 0.0% |
| Q3 2021 | $7,003,000 | +18.8% | 655,094 | +72.4% | 0.01% | +16.7% |
| Q2 2021 | $5,896,000 | +44.4% | 379,899 | +50.9% | 0.01% | +20.0% |
| Q1 2021 | $4,082,000 | -15.9% | 251,831 | +9.8% | 0.01% | 0.0% |
| Q4 2020 | $4,854,000 | +56.8% | 229,351 | +9.8% | 0.01% | +25.0% |
| Q3 2020 | $3,096,000 | +11.2% | 208,928 | +10.4% | 0.00% | 0.0% |
| Q2 2020 | $2,784,000 | +28.7% | 189,228 | +2.7% | 0.00% | +33.3% |
| Q1 2020 | $2,164,000 | -47.8% | 184,328 | +4.5% | 0.00% | -40.0% |
| Q4 2019 | $4,146,000 | +34.3% | 176,434 | +5.7% | 0.01% | +25.0% |
| Q3 2019 | $3,088,000 | +0.9% | 166,934 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $3,061,000 | -11.1% | 164,676 | +16.9% | 0.00% | 0.0% |
| Q1 2019 | $3,443,000 | +3.3% | 140,896 | +9.6% | 0.00% | -20.0% |
| Q4 2018 | $3,333,000 | +48.3% | 128,503 | +81.0% | 0.01% | +66.7% |
| Q3 2018 | $2,247,000 | -18.5% | 71,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,758,000 | +69.9% | 71,000 | +20.7% | 0.00% | +50.0% |
| Q1 2018 | $1,623,000 | +84.4% | 58,800 | +21.0% | 0.00% | +100.0% |
| Q4 2017 | $880,000 | +12.1% | 48,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $785,000 | +16.6% | 48,600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $673,000 | +10.1% | 48,600 | +19.4% | 0.00% | 0.0% |
| Q1 2017 | $611,000 | +33.1% | 40,701 | +16.3% | 0.00% | 0.0% |
| Q4 2016 | $459,000 | -23.9% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $603,000 | -4.6% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $632,000 | +13.3% | 35,000 | +19.0% | 0.00% | 0.0% |
| Q1 2016 | $558,000 | -28.9% | 29,400 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $785,000 | +16.1% | 29,400 | +6.1% | 0.00% | 0.0% |
| Q3 2015 | $676,000 | -12.3% | 27,700 | +12.0% | 0.00% | 0.0% |
| Q2 2015 | $771,000 | – | 24,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |